| Name | Title | Contact Details |
|---|
Avride is a prominent developer in the autonomous vehicle and delivery robot sector, established in 2017 and based in Ann Arbor, Michigan. The company aims to lead the future of autonomous transportation by creating safer and more sustainable mobility solutions. Avride specializes in autonomous passenger transportation and contactless delivery solutions. It has launched Europes first autonomous taxi service without a human driver, integrating these vehicles into everyday life. Additionally, Avride offers delivery robots that enhance logistics efficiency for partners in various countries. The companys product lineup includes autonomous cars equipped with advanced technology such as proprietary lidar systems, camera systems, and radar systems for comprehensive object detection. Their delivery robots are designed for reliable operations, moving at speeds of 5-8 kph. Avride has served over 250,000 customers, collaborating with partners in the U.S. and South Korea to improve service quality.
VSB Bancorp, Inc. is one of the leading companies in Business Services industry. VSB Bancorp, Inc. is based in Staten Island, NY. You can find more information on VSB Bancorp, Inc. at www.victorystatebank.com
Adfarm is a Kansas City, MO-based company in the Business Services sector.
Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.
Hayes Martin Associates is a Newport Beach, CA-based company in the Business Services sector.